A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2002
11/20/2002	EP0776325B1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
11/20/2002	EP0752865B1 Use of substituted dextrane for treating nervous system damage, and heparane sulphate-enriched fractions
11/20/2002	EP0750507B1 Proteasome regulation of nf-kappa-b activity
11/20/2002	EP0547151B1 Treatment process for promoting weight loss employing a substituted delta 5-androstene
11/20/2002	CN1380883A Novel derivatives and analogues of galanthamin
11/20/2002	CN1380289A Amide capable of inhibiting ApoB-secretion/MTP
11/20/2002	CN1380097A Growth hormone liposome for pig and its preparation method
11/20/2002	CN1380066A Fattening injection preparation for pork type pig
11/20/2002	CN1380058A Medicine for promoting synthesis of human self-body EPA and DHA
11/20/2002	CN1094490C Quinolein-2(1H)-one derivativs as serotonin antagonists
11/20/2002	CN1094369C Chinese medicinal herbs extractive and its application
11/20/2002	CN1094362C Traditional Chinese medicinal pill with function of benefiting kidney and primordial energy
11/20/2002	CN1094359C Pear syrup for nourishing lungs
11/20/2002	CA2410038A1 Gelling composition
11/19/2002	US6482986 Benzene derivatives, preparation method and pharmaceutical compositions containing same
11/19/2002	US6482956 Endothelin receptor antagonists
11/19/2002	US6482951 Isoindolin-1-one glucokinase activators
11/19/2002	US6482948 Thienopyrimidine compounds and salts thereof and process for the preparation of the same
11/19/2002	US6482935 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/19/2002	US6482929 Antibodies to ARF-p19
11/19/2002	US6482852 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
11/19/2002	US6482848 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/19/2002	US6482846 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/19/2002	US6482842 3-aminopyrazole inhibitors of cyclin dependent kinases
11/19/2002	US6482836 CRF antagonistic quino- and quinazolines
11/19/2002	US6482834 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
11/19/2002	US6482832 Heterocyclically substituted amides, their production and their use
11/19/2002	US6482830 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
11/19/2002	US6482829 Central nervous system disorders; heeadaches, antiinflammatory agents
11/19/2002	US6482825 Growth-hormone secretagogues
11/19/2002	US6482824 Use of n-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives as selective mglur1 antagonists
11/19/2002	US6482822 N-(iminomethyl)amines derivatives, their preparation, their use as medicines and compositions containing them
11/19/2002	US6482819 2,3-benzodiazepine derivatives
11/19/2002	US6482816 Organic arsenic compounds
11/19/2002	US6482815 Organic-arsenic compounds
11/19/2002	US6482798 Aprotinin variants having a net charge of +3 to -3 at ph 7 and with the amino acids arg15 or arg15-ala17 in the binding region; serine protease inhibitor
11/19/2002	US6482797 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ACE)
11/19/2002	US6482616 RCA-free adenoviral vector system and propagation method
11/19/2002	US6482612 Adipocyte-specific protein homologs
11/19/2002	US6482609 Isolated human EDG-4 receptor and polynucletide encoding said receptor
11/19/2002	US6482426 Compositions for the treatment of male erectile dysfunction
11/19/2002	US6482396 Combination of lactoferrin (lf) and glycomacropeptide (gmp) that exerts an antimicrobial effect in oral cavities
11/19/2002	US6481435 Closure-cap and container as a two-chamber cartridge for nebulizers for producing aerosols and active substance formulations, suitable for storage
11/19/2002	CA2312667C Novel cytokine
11/19/2002	CA2252513C Method for the prevention and treatment of cachexia and anorexia
11/19/2002	CA2225780C New derivatives of n-benzylpiperazine, their preparation process and the pharmaceutical compositions they contain
11/19/2002	CA2216870C Compositions and methods for regulating hair growth
11/19/2002	CA2156512C Treatment of androgen-associated baldness using antisense oligomers
11/19/2002	CA2153546C Periwinkle grain extract and composition containing the same
11/19/2002	CA2091700C A non-mitogenic competitive hgf antagonist
11/19/2002	CA2061706C Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
11/19/2002	CA2044143C Method of preventing or limiting reperfusion damage
11/19/2002	CA1341398C Expression of biologically active pdgf analogs in eucaryotic cells
11/18/2002	WO2001087855A1 Triazole derivatives
11/16/2002	CA2383556A1 High-efficiency assay for protein mannosyl transferases
11/15/2002	WO2001090053A1 Diphenylmethane derivatives
11/15/2002	CA2409144A1 Diphenylmethane derivatives
11/14/2002	WO2002090567A2 Sperm-specific cation channel, and uses therefor
11/14/2002	WO2002090566A2 Recombinant tumor specific antibody and use thereof
11/14/2002	WO2002090553A2 Recombinant fusion proteins and the trimers thereof
11/14/2002	WO2002090546A1 Polypeptide serving as angiogenic marker and dna thereof
11/14/2002	WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	WO2002090514A2 Epidermal growth factor receptorantisense oligonucleotides
11/14/2002	WO2002090499A2 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/14/2002	WO2002090385A1 Protein polymer having unfold activity on higher-order structure of protein
11/14/2002	WO2002090375A2 Liver x receptor agonists
11/14/2002	WO2002090361A1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/14/2002	WO2002090358A1 Disubstituted 7,9-guaninium halides as telomerase inhibitors
11/14/2002	WO2002090357A1 Disubstituted 1,7-guanines
11/14/2002	WO2002090355A1 N-aroyl cyclic amines
11/14/2002	WO2002090354A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides
11/14/2002	WO2002090353A1 Sulfonamides
11/14/2002	WO2002090352A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
11/14/2002	WO2002090349A1 N-oxide anthranylamide derivatives and their use as medicaments
11/14/2002	WO2002090348A1 Sulfonamides
11/14/2002	WO2002090347A1 Amide compounds
11/14/2002	WO2002090346A1 Phthalazine derivatives with angiogenesis inhibiting activity
11/14/2002	WO2002090334A1 Isoquinolinone derivatives as parp inhibitors
11/14/2002	WO2002090332A2 Novel aeylheteroalkylaminε derivatives
11/14/2002	WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002090326A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
11/14/2002	WO2002090325A2 Benzazepinone alpha v integrin receptor antagonists
11/14/2002	WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002090304A1 Stable solution of reduced coenzyme q
11/14/2002	WO2002089858A1 Azo compounds for type i phototherapy
11/14/2002	WO2002089842A1 Combination therapy using anti-egfr antibodies and anti-hormonal agents
11/14/2002	WO2002089841A2 Method of preventing cell death using antibodies to neural thread proteins
11/14/2002	WO2002089835A2 Pharmaceutical dosage form of amorphous nelfinavir mesylate
11/14/2002	WO2002089832A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
11/14/2002	WO2002089831A1 Preventives/remedies for nephritis
11/14/2002	WO2002089825A1 Medicinal herbal compounds for the prevention and treatment of diabetes
11/14/2002	WO2002089824A1 Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof
11/14/2002	WO2002089809A1 Medicinal uses of hydrazones and hydrazines
11/14/2002	WO2002089807A1 Timing and duration of administration of adenosine a1/a2 agonist for cardioprotection
11/14/2002	WO2002089806A1 Heterobicycles fkbp-ligands
11/14/2002	WO2002089804A1 Alpha-2-adrenergic agonist/fatty acid compositions
11/14/2002	WO2002089800A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/14/2002	WO2002089796A2 Methods for selective immunomodulation using pimecrolimus
11/14/2002	WO2002089795A1 Method for treatment of tumors using nordihydroguaiaretic acid derivatives
11/14/2002	WO2002089793A1 Sulfonamides

1 ... 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 ... 1564